We found that mRNA expression of EphB2 was significantly upregulated in human fibrotic liver (GSE193066) [30], cirrhotic liver and HCC tumors (GSE25097) [31], and was positively correlated with the progression of liver dysfunction (Fig. S1A). This evidence concerns the gene EPHB2 and hepatocellular carcinoma.